Utility of 18F-Fluoro-Deoxyglucose EmisiOn Tomography/Computed and Sentinel Node Biopsy for Axillary Staging in Primary Breast Cancer. Roffo PET/CT 1 Trial

被引：0
|
作者：
Noblia, C. M.
Cresta Morgado, C. E.
Azar, M. E.
Bruno, G.
Gonzalez, C.
Parma, P.
Gonzalez, E. G.
Armanasco, E.
Montoya, D.
Ipina, J. M.
Zarlenga, C.
Gorostidi, S.
机构：
[1] CABA, Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina
[2] CABA, Fdn Ctr Diagnost Nucl, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P1-01-28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-01-28
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Potential role of positron emission tomography/computed tomography with fluorodeoxyglucose (18F-FDG PET/CT) in the initial staging of breast cancer
    Sanchez, Rocio
    Jimenez, Antonio Daniel Gonzalez
    Luquin, Tariq Aroui
    Arnau, Inmaculada Mendoza
    Herrezuelo, Isabel Perez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2025, 38 (01):
  • [22] 18F-FDG PET-CT utility in initial axillary staging in locally advanced breast cancer candidates to neoadjuvant chemotherapy
    Serrano Palacio, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S473 - S473
  • [23] Lymph Node to Primary Tumor SUV Ratio by 18F-FDG PET/CT and the Prediction of Axillary Lymph Node Metastases in Breast Cancer
    Park, Jihyun
    Byun, Byung Hyun
    Noh, Woo Chul
    Lee, Seung Sook
    Kim, Hyun-Ah
    Kim, Eun-Kyu
    Choi, Chang Woon
    Lim, Sang Moo
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (04) : E249 - E253
  • [24] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    CANCER, 2009, 115 (21) : 5038 - 5047
  • [25] F-18 fluoro-d-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers
    Mehmet Dolanbay
    Bulent Ozcelik
    Ummuhan Abdulrezzak
    Ibrahim Serdar Serin
    Mehmet Serdar Kutuk
    Semih Uludag
    Archives of Gynecology and Obstetrics, 2016, 293 : 1319 - 1324
  • [26] F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers
    Dolanbay, Mehmet
    Ozcelik, Bulent
    Abdulrezzak, Ummuhan
    Serin, Ibrahim Serdar
    Kutuk, Mehmet Serdar
    Uludag, Semih
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (06) : 1319 - 1324
  • [27] The benefit of 18F-FDG PET/CT in the follow-up of breast cancer with positive sentinel lymph node without axillary dissection
    Savolt, Akos
    Peley, Gabor
    Toth, Laszlo
    Matrai, Zoltan
    Renyi-Vamos, Ferenc
    Polgar, Csaba
    Horvath, Zsolt
    Szabo, Eva
    Borbely, Katalin
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [28] Diagnostic and prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in detecting multifocality and axillary lymph node metastasis and correlation of clinicopathologic factors in primary breast cancer
    Kwak, B. S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 230 - 230
  • [29] A prospective phase II trial to evaluate the feasibility of omit sentinel lymph node biopsy after integrate18F-FDG dedicated axillary PET in early breast cancer: SOAPET trial
    Li, Junjie
    Cheng, Jingyi
    Liu, Guangyu
    Hou, Yifeng
    Di, Genghong
    Yang, Benlong
    Jiang, Yizhou
    Huang, Liang
    Chen, Sheng
    Wang, Yan
    Yu, Keda
    Shao, Zhimin
    CANCER RESEARCH, 2021, 81 (04)
  • [30] Axillary staging after neoadjuvant chemotherapy: The comparison of surgeon performed axillary ultrasound and 18F-FDG PET/CT with pathologic status of sentinel lymph nodes in clinically node-negative breast cancer
    Cakmak, Guldeniz Karadeniz
    Uslu, Rabiye
    Emre, Ali U.
    Elmas, Ozlem
    Karadere, Yucel
    Konuk, Mine Buse
    Engin, Huseyin
    Gun, Banu Dogan
    CANCER RESEARCH, 2018, 78 (04)
12345